Commission Implementing Regulation (EU) 2025/2154 of 17 October 2025 laying down good manufacturing practice for active substances used as starting materials in veterinary medicinal products in accordance with Regulation (EU) 2019/6 of the European Parliament and of the Council
Article 7Responsibilities of the production unit
In force · version of Nov 16, 2025
The responsibilities for production activities shall be documented in writing, and shall include at least the following elements:
— preparation, review, approval and distribution of the instructions for the production of active substances or intermediates thereof in accordance with written procedures;
— production of active substances and, when appropriate, intermediates in accordance with pre-approved instructions;
— review of all production batch records and ensuring that they are completed and signed;
— reporting and evaluation of all production deviations, investigation of critical deviations and recording of the conclusions;
— cleaning and when appropriate disinfection of production premises;
— performing of the calibrations and keeping the records of those calibrations;
— maintenance of the premises and equipment and keeping the records of the maintenance activities;
— review and approval of the validation protocols and reports;
— evaluation of proposed changes in product, process or equipment;
— ensuring the qualification of new and modified facilities and equipment.